Moreover, we provided evidence suggesting that the overexpression of GAS5 ameliorated RP-induced electrical remodeling of atrial cardiomyocytes, possibly via the GAS5/miR-27a-3p/HOXa10 pathway, suggesting the possibility of a potential therapeutic target for AF, which warrants further studies for verification. This evidence concerns the gene HOXA10 and atrial fibrillation.